As mentioned, we have shown that Sirt2 knockout mice with a KRASG12D mutation background develop pancreatic cancer, suggesting Sirt2 knockout is susceptible for pancreatic cancer11. The gene discussed is SIRT2; the disease is pancreatic neoplasm.